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Background: Lichen planus is an idiopathic inflammatory 
disease of the skin and mucous membranes. Although the etiology 
is not established, it has been associated with autoimmune diseases, 
viral infections, drugs and dental restoration materials. However, 
the association with inflammatory bowel disease has been very 
rarely reported in the literature. Case Report: A 19-year-old female 
patient presented with annular lesions on her upper body and limbs, 
with a sharply defined border and non-atrophic skin in the center. 
The lesions were hyperpigmented and had been stable for over one 
year. The histopathology confirmed the diagnosis of annular lichen 
planus. She had weight loss, occasional diarrhea, and a severe 
anemia. The investigation of these symptoms led to the diagnosis 
of Crohn disease and a sickle cell trait. Therapy with systemic 
corticosteroids and mesalazine controlled the intestinal disease, 
with concomitant improvement of the skin lesions. Conclusions: 
As lichen planus can be associated with other immunological 
disorders, the association with inflammatory bowel disease should 
be considered in the evaluation of the patient.  
 
Introduction 
Lichen planus (LP) is an idiopathic inflammatory disease that 
can present with both skin and mucosal involvement [1]. It is 
considered an autoimmune disease mediated by CD8+ T cells, 
against basal keratinocytes that express modified epitopes [2, 3]. 
This can be the result of viral infection or vaccination, drugs, 
contact allergens and rarely underlying neoplasms [4, 5, 6, 7]. 
Annular LP is a rare variant affecting about 10 percent of patients 
and tends to have a chronic evolution [8]. Inflammatory bowel 
disease (IBD) can have many skin manifestations, but there are 






Figure 1 Figure 2 
Figure 1. Multiple annular asymptomatic lesions 
Figure 2. Annular lesions on the back, with sharply defined 
borders 
A 19-year-old female patient, presented with multiple annular 
lesions for more than a year. 
 
  
Figure 3 Figure 4 
Figure 3. Detail of a lesion on the back, showing the slightly 
elevated border 
Figure 4. Lesion on the arm, with non-scaling elevated 
border and central hyperpigmentation 
The lesions presented with non-atrophic, hyperpigmented 
central areas and non-scaling, slightly elevated borders. Twenty-
three annular lesions were present, ranging from 2 to 8cm in 
diameter. They appeared simultaneously, had initial centrifugal 
growth, and remained stable for one year despite the use of topical 
any systemic medication prior to the appearance of the skin lesions. 
 
  
Figure 5 Figure 6 
Figure 5. Annular lichen planus, multiple lesions 
Figure 6. Annular lichen planus, showing characteristic 
histological changes on the elevated lesion border (H&E, 
x100) 
The plaques were mostly on the trunk and upper limbs and 
although they were initially pruritic they were otherwise 
asymptomatic. No mucosal, genital, or nail changes were observed. 
The histopathological examination of the lesion border 
revealed focal hyperkeratosis, epidermal hyperplasia, and wedge-
shaped hypergranulosis. A band-like lichenoid lymphocytic 
inflammatory infiltrate was present with numerous melanophages. 
Cytoid bodies and subepidermal clefting (Max-Joseph spaces) 
could also be seen. 
 
The central area showed 
hyperkeratosis, epidermal 
flattening and numerous 
melanophages in the superficial 
dermis (pigment incontinence) 
with a scarce lymphohistiocytic 
infiltrate. An Orcein stain showed 
no changes in the elastic fibers. 
The findings were consistent with 
annular lichen planus. 
The patient was of African 
descent and had prior laboratory 
evidence of chronic microcytic 
hypochromic anemia 
(hemoglobin: 8.6 g/dl, mean 
corpuscular volume: 55.8 fl). Self-
limited episodes of abdominal 
pain and diarrhea had been present for the last six months, with 
mild to moderate intensity, without visible pus or blood. Due to the 
 
Figure 7 
Figure 7. Biopsy from the 
center of the lesion with 
post-inflammatory changes 
such as scarce 
inflammatory infiltrate and 
pigment incontinence 
(H&E, x100) 
sudden worsening of the anemia (hemoglobin: 6.1 g/dl), the patient 
was admitted to the internal medicine department. Infections by the 
hepatitis B and C viruses, human immunodeficiency virus 1 and 2, 
Mycobacterium tuberculosis and intestinal parasites were excluded. 
Sickle cell trait was diagnosed (hemoglobin S: 27.6%), but 
very low iron and ferritin levels and high sedimentation rate 
(74mm/h) were present, justifying further investigation.  
 
The abdominal computer 
tomography revealed a uniform 
circumferential thickening from 
the ascending colon to the 
terminal ileum. The colonoscopy 
showed mucosal deformities and 
pseudo-polypoid images with 
vegetating and ulcerative areas. 
The biopsy taken was compatible 
with Crohn disease, and therapy 
was started with prednisolone 
(60mg/day) and mesalazine (1g 
6/6h), with rapid response of both 
intestinal and cutaneous lesions. 
 
  
Figure 9 Figure 10 
Figure 9. Successful therapy of the intestinal disease with 
prednisolone and mesalazine and simultaneous improvement 
of the skin disease 
Figure 10. Residual hyperpigmented macules, showing 
central clearing 
After one month of therapy the elevated border disappeared, 




Figure 8. Abdominal 
computer tomography: The 
mucosa of the colon and 
terminal ileum shows 
circumferential thickening 
The prednisolone dose was 
slowly tapered to 10mg/day and 
mesalazine was maintained; at 17 
months, follow-up showed no 




Annular lichen planus is an 
uncommon subtype of LP, usually 
presenting with small annular 
lesions, with elevated borders and 
central clearing [8]. Although 
initially thought to be more common in black patients, recent 
studies have not shown racial differences [11]. The male genitals 
and intertriginous areas are the more frequently affected locations 
and usually there are no lesions on the nails or mucosal sites [8, 
11]. Annular lesions can occur associated with typical LP lesions, 
but most patients present with annular lesions only [11]. Annular 
atrophic LP might be considered another subtype, with central 
areas showing elastolysis secondary to previous inflammatory 
activity [12]; actinic LP presents with red-brown annular lesions 
mostly on sun-exposed skin [13]. In our patient the histopathology 
showed disease activity only in the elevated border and the central 
areas had a normal network of elastic fibers. The lesions were 
mostly on sun-protected sites. 
LP has been associated with infections, autoimmune diseases, 
drugs, and contact allergies to metals, but the association with 
inflammatory bowel disease has very rarely been reported [4, 6, 
10]. Crohn disease and LP have been described together in only 
two previous reports [9, 14]. In a review of 711 LP cases 
performed by an Italian group, only five patients (0.7%) had 
associated ulcerative colitis [10], and very few other reports on this 
association have been published [15-20]. The etiopathogenesis is 
not well understood, but the deposition of antigens or immune 
complexes of intestinal origin might trigger the cutaneous response 
[2, 3, 4]. This is one of the probable mechanisms responsible for 
other cutaneous associations of IBD, such as pyoderma 
gangrenosum, erythema nodosum, intestinal bypass syndrome, and 
cryoglobulinemia [21, 22]. The coincidence in the timing of 
appearance of both diseases and the response to therapy of both 
intestinal and skin lesions favors this association. Even so, the 
small number of cases could be interpreted as coincidental and 
systemic corticosteroids and sulphonamides can treat the skin 
lesions independently of their effect on the bowel disease [23]. 
Inflammatory bowel disease is frequently associated with skin 
 
Figure 11 
Figure 11. Detail of the 
lesion on the arm after 
therapy: The elevated 
border disappeared, leaving 
a residual hyperpigmented 
lesion. 
disease and the fact they share an immunological pathogenesis 
makes this association probable. Further cases could help in 
confirming the association between both diseases.  
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